86 related articles for article (PubMed ID: 15721450)
41. Prognostic value of Ca 125 levels during primary therapy.
Markmann S; Gerber B; Briese V
Anticancer Res; 2007; 27(4A):1837-9. PubMed ID: 17649781
[TBL] [Abstract][Full Text] [Related]
42. Preoperative predictors for residual tumor after surgery in patients with ovarian carcinoma.
de Jong D; Eijkemans MJ; Lie Fong S; Gerestein CG; Kooi GS; Baalbergen A; van der Burg ME; Burger CW; Ansink AC
Oncology; 2007; 72(5-6):293-301. PubMed ID: 18198490
[TBL] [Abstract][Full Text] [Related]
43. Total procollagen type 1 amino-terminal propeptide (total P1NP) as a bone metastasis marker in gynecological carcinomas.
Oremek G; Sauer-Eppel H; Klepzig M
Anticancer Res; 2007; 27(4A):1961-2. PubMed ID: 17649805
[TBL] [Abstract][Full Text] [Related]
44. The myth of measurable disease in ovarian cancer: revisited.
Markman M
Cancer Invest; 2009 Jan; 27(1):11-2. PubMed ID: 19160094
[TBL] [Abstract][Full Text] [Related]
45. Is there a correlation between tumor marker panel and tumor size and histopathology in well staged patients with borderline ovarian tumors?
Ayhan A; Guven S; Guven ES; Kucukali T
Acta Obstet Gynecol Scand; 2007; 86(4):484-90. PubMed ID: 17486473
[TBL] [Abstract][Full Text] [Related]
46. A doctor talks about. Screening for ovarian cancer.
Robb-Nicholson C
Harv Womens Health Watch; 2004 Sep; 12(1):5. PubMed ID: 15381472
[No Abstract] [Full Text] [Related]
47. Statistical interpretation of CA125 and Bcl-2 in serum of patients with late stage ovarian cancer.
Camlica H; Duranyildiz D; Tas F; Yasasever V
Am J Clin Oncol; 2008 Dec; 31(6):585-8. PubMed ID: 19060592
[TBL] [Abstract][Full Text] [Related]
48. Correlation of MDR 1 expression and CA 125 in ovarian cancer.
Galani E; Skarlos D; Sgouros J; Litos M; Gonos E; Dionyssiou-Asteriou A
In Vivo; 2005; 19(4):797-800. PubMed ID: 15999552
[TBL] [Abstract][Full Text] [Related]
49. Proteomic profiling identifies afamin as a potential biomarker for ovarian cancer.
Jackson D; Craven RA; Hutson RC; Graze I; Lueth P; Tonge RP; Hartley JL; Nickson JA; Rayner SJ; Johnston C; Dieplinger B; Hubalek M; Wilkinson N; Perren TJ; Kehoe S; Hall GD; Daxenbichler G; Dieplinger H; Selby PJ; Banks RE
Clin Cancer Res; 2007 Dec; 13(24):7370-9. PubMed ID: 18094419
[TBL] [Abstract][Full Text] [Related]
50. [Pelvic tumor, elevated CA 125 level and tuberculosis].
Belletti GA; Millán AE; López A; Yorio MA; Jakob E; Bouchet D; Irico G
Medicina (B Aires); 2005; 65(2):181-2. PubMed ID: 16075819
[No Abstract] [Full Text] [Related]
51. CA-125 blood test in early detection of ovarian cancer.
Burki TK
Lancet Oncol; 2015 Jun; 16(6):e269. PubMed ID: 25975633
[No Abstract] [Full Text] [Related]
52. Elevation of tumour marker CA-125 in serum & body fluids: interpret with caution.
Hussain SF; Camilleri P
Indian J Med Res; 2007 Jan; 125(1):10-2. PubMed ID: 17332651
[No Abstract] [Full Text] [Related]
53. A focus on important reproductive health care issues - cancer, urinary incontinence and the consequences of pre-term birth.
Milsom I; Geirsson RT
Acta Obstet Gynecol Scand; 2010; 89(2):163-4. PubMed ID: 20121332
[No Abstract] [Full Text] [Related]
54. Re: New guidelines to evaluate the response to treatment in solid tumors (ovarian cancer).
Taylor PT; Haverstick D
J Natl Cancer Inst; 2005 Jan; 97(2):151; author reply 152. PubMed ID: 15657346
[No Abstract] [Full Text] [Related]
55. CA-125: an evolving role in the management of ovarian cancer.
Markman M
J Clin Oncol; 1996 May; 14(5):1411-2. PubMed ID: 8622053
[No Abstract] [Full Text] [Related]
56. Pericardial effusion with elevated serum carbohydrate antigen 125 levels and ovarian tumor mass.
Patanè S; Marte F; Di Bella G; Davi' M
Int J Cardiol; 2008 Jul; 127(3):e105-7. PubMed ID: 17448553
[No Abstract] [Full Text] [Related]
57. Ovarian cancer screening.
Eason EL
CMAJ; 2005 Feb; 172(4):447. PubMed ID: 15710918
[No Abstract] [Full Text] [Related]
58. Rise of serum CA 125 in patients with pure ovarian yolk sac tumors.
Sekiya S; Seki K; Nagai Y
Int J Gynaecol Obstet; 1997 Sep; 58(3):323-4. PubMed ID: 9286871
[No Abstract] [Full Text] [Related]
59. Normal CA-125 and the risk of progression in ovarian cancer.
Markman M
J Clin Oncol; 2006 Jul; 24(20):3310; author reply 3310-1. PubMed ID: 16829656
[No Abstract] [Full Text] [Related]
60. CA-125 for diagnosis of acute appendicitis: new possibility for an old tumor marker.
Basaran A
Colorectal Dis; 2010 Feb; 12(2):155-6. PubMed ID: 19799616
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
